BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 9200332)

  • 1. Imaging in Tumor Immunology.
    Kim EE; Youn H; Kang KW
    Nucl Med Mol Imaging; 2021 Oct; 55(5):225-236. PubMed ID: 34721715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.
    Brassesco MS; Xavier DJ; Camparoto ML; Montaldi AP; de Godoy PR; Scrideli CA; Tone LG; Sakamoto-Hojo ET
    J Biomed Biotechnol; 2011; 2011():. PubMed ID: 20871850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qualitatively and quantitatively similar effects of active and passive maternal tobacco smoke exposure on in utero mutagenesis at the HPRT locus.
    Grant SG
    BMC Pediatr; 2005 Jun; 5():20. PubMed ID: 15987524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors.
    Williams CJ; Grandal I; Vesprini DJ; Wojtyra U; Danska JS; Guidos CJ
    Mol Cell Biol; 2001 Jan; 21(2):400-13. PubMed ID: 11134329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of V(D)J recombination induces the formation of interlocus joints and hybrid joints in scid pre-B-cell lines.
    Lew S; Franco D; Chang Y
    Mol Cell Biol; 2000 Oct; 20(19):7170-7. PubMed ID: 10982833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for Atm in suppressing V(D)J recombination-driven thymic lymphoma.
    Liao MJ; Van Dyke T
    Genes Dev; 1999 May; 13(10):1246-50. PubMed ID: 10346813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No requirement for V(D)J recombination in p53-deficient thymic lymphoma.
    Liao MJ; Zhang XX; Hill R; Gao J; Qumsiyeh MB; Nichols W; Van Dyke T
    Mol Cell Biol; 1998 Jun; 18(6):3495-501. PubMed ID: 9584189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-specific genomic instability and risk of lymphoid malignancy.
    Kirsch IR; Lista F
    Semin Immunol; 1997 Jun; 9(3):207-15. PubMed ID: 9200332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transrearrangements as biomarkers for risk of lymphoid malignancy.
    Kirsch IR; Lista F
    Cancer Surv; 1996; 28():311-27. PubMed ID: 8977043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accessibility and the developmental regulation of V(D)J recombination.
    Schlissel MS; Stanhope-Baker P
    Semin Immunol; 1997 Jun; 9(3):161-70. PubMed ID: 9200327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absolute number of trans-rearrangements between the TCRG and TCRB loci is predictive of lymphoma risk: a severe combined immune deficiency (SCID) murine model.
    Lista F; Bertness V; Guidos CJ; Danska JS; Kirsch IR
    Cancer Res; 1997 Oct; 57(19):4408-13. PubMed ID: 9331104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal translocations in lymphoid neoplasia: a reappraisal of the recombinase model.
    Tycko B; Sklar J
    Cancer Cells; 1990 Jan; 2(1):1-8. PubMed ID: 2201335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies.
    Lipkowitz S; Garry VF; Kirsch IR
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5301-5. PubMed ID: 1608939
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.